Jan 7, 2025 7:00 am EST iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio
Jan 2, 2025 7:00 am EST iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio